Juvenile myelomonocytic leukaemia

ABSTRACT

Juvenile Myelomonocytic Leukemia [JMML] is a rare hematopoietic malignancy of early childhood. Infection remains the principal cause of death in patients with myelodysplastic syndrome [MDS]. Sixty percent of patients are anemic and 26 percent have petechiae and/or purpura [thrombocytopenia]. Bone Marrow Transplant [BMT] is the best available treatment option. We describe the management of an eight months old male child who presented with complaints of fever, cough and pallor since six months. Despite medication his fever did not subside. He developed meningitis and intracranial bleed and expired on 11th day of hospitalization